यह जानकारी केवल शैक्षणिक उद्देश्यों के लिए है। हमेशा किसी स्वास्थ्य सेवा पेशेवर से परामर्श लें। और जानें
Condition-Specific Drug Guides · 11 मिनट पढ़ें

Complete Guide to Depression Medications

A compassionate overview of antidepressant drug classes — SSRIs, SNRIs, TCAs, MAOIs, and newer options — covering how they work, what to expect, and important safety information.

Understanding Depression and Brain Chemistry

Depression is a medical condition involving changes in brain chemistry, structure, and function — not simply a matter of willpower or mood. Neurotransmitters (chemical messengers) including serotonin, norepinephrine, and dopamine play roles in mood regulation, though the relationship is more complex than the simplified "chemical imbalance" explanation often cited.

Antidepressants work by modifying how these neurotransmitters are released, reabsorbed, or broken down — but the full mechanism of why this relieves depression (often weeks after the chemical changes begin) is still being researched. What is clear is that antidepressants are effective for moderate-to-severe depression and are often used alongside therapy.

SSRIs: The Most Common Starting Point

Selective serotonin reuptake inhibitors (SSRIs) are the most frequently prescribed antidepressants because they are effective, generally well tolerated, and safe in overdose.

Common examples: fluoxetine (Prozac), sertraline (Zoloft), escitalopram (Lexapro), paroxetine (Paxil), citalopram (Celexa), fluvoxamine.

SSRIs block the reabsorption (reuptake) of serotonin in the synapse between nerve cells, increasing serotonin availability. They are selective in that they act primarily on serotonin transporters, with less effect on other receptors.

Common side effects include nausea (usually temporary), sexual dysfunction (delayed orgasm, reduced libido — affects 30–40% of users), insomnia or sedation, and weight changes with long-term use.

How Receptor Selectivity Shapes Side Effects

Receptor selectivity — how precisely a drug targets specific receptors — largely determines its side effect profile. SSRIs differ from each other in subtle ways:

  • Paroxetine is less selective, also blocking muscarinic acetylcholine receptors — causing more dry mouth, constipation, and sedation than other SSRIs.
  • Fluoxetine has a very long half-life (days to weeks), making it forgiving if a dose is missed but requiring a longer washout before switching.
  • Citalopram at high doses can affect heart rhythm (QT prolongation) — limiting the maximum dose.
  • Escitalopram is the pure active form of citalopram, generally considered among the cleanest SSRI profiles.

SNRIs

Serotonin-norepinephrine reuptake inhibitors (SNRIs) block reuptake of both serotonin and norepinephrine. The added norepinephrine effect can improve energy, concentration, and pain relief.

Common examples: venlafaxine (Effexor), duloxetine (Cymbalta), desvenlafaxine (Pristiq), levomilnacipran (Fetzima).

SNRIs are often preferred when depression coexists with anxiety, chronic pain, or fibromyalgia. Duloxetine is FDA-approved for both major depression and several pain conditions. Venlafaxine can raise blood pressure at higher doses and has a notably difficult discontinuation syndrome — doses should be tapered slowly.

Bupropion: An NDRI

Bupropion (Wellbutrin, Zyban) works differently from SSRIs and SNRIs — it blocks the reuptake of norepinephrine and dopamine (NDRI). It does not significantly affect serotonin.

Key advantages: - No sexual side effects (making it useful when SSRIs cause this problem) - Often causes weight loss rather than gain - Also FDA-approved for smoking cessation (as Zyban)

Key cautions: - Lowers the seizure threshold — contraindicated in people with eating disorders or seizure history - Can be activating — worsening anxiety or causing insomnia in some people

Mirtazapine

Mirtazapine works through a different mechanism: it blocks certain presynaptic receptors (alpha-2 adrenergic and serotonin receptors), indirectly increasing the release of both norepinephrine and serotonin.

It is sedating — often prescribed in patients with insomnia or poor appetite, as it tends to increase both sleep and hunger. The sedation paradoxically decreases at higher doses. It does not cause sexual side effects and is an option for people who cannot tolerate SSRIs.

Tricyclic Antidepressants (TCAs)

TCAs (amitriptyline, nortriptyline, imipramine, desipramine) were among the first antidepressants developed. They are effective but have a broader receptor profile — affecting serotonin, norepinephrine, histamine, acetylcholine, and others — producing more side effects.

Common TCA side effects: dry mouth, constipation, urinary retention, blurred vision, sedation, weight gain, and orthostatic hypotension (dizziness on standing). More concerning is their cardiac toxicity in overdose, which is why they are not a first choice in patients at suicide risk.

TCAs are still used for treatment-resistant depression, chronic pain, and certain sleep disorders.

MAOIs

Monoamine oxidase inhibitors (phenelzine, tranylcypromine, selegiline) block an enzyme that breaks down serotonin, norepinephrine, and dopamine. They are highly effective but require a strict low-tyramine diet to prevent hypertensive crisis.

Tyramine — found in aged cheeses, cured meats, red wine, and many other foods — is normally metabolized by MAO in the gut. When MAO is blocked, tyramine accumulates and can trigger a dangerous spike in blood pressure.

MAOIs are rarely used now but remain an option for treatment-resistant depression or atypical depression.

Newer Agents

Several newer antidepressants target different mechanisms:

  • Vortioxetine (Trintellix): Modulates multiple serotonin receptor subtypes in addition to reuptake inhibition. May improve cognitive symptoms of depression.
  • Vilazodone (Viibryd): SSRI plus partial agonist at serotonin 5-HT1A receptors.
  • Esketamine (Spravato): A nasal spray form of ketamine for treatment-resistant depression; rapid onset (hours), used in supervised clinical settings.
  • Brexanolone (Zulresso): An intravenous treatment for postpartum depression targeting GABA receptors.

Serotonin Syndrome: A Serious Risk

Serotonin syndrome is a potentially dangerous condition caused by too much serotonin activity in the nervous system, usually from combining multiple serotonergic drugs. Symptoms range from mild (tremor, diarrhea, agitation) to life-threatening (high fever, muscle rigidity, seizures).

Common drug combinations that can trigger it: - Two SSRIs combined - SSRI + SNRI - SSRI + tramadol, linezolid, or methylene blue - SSRI + some triptans (migraine drugs)

Always inform every prescriber about all your medications. This is one reason drug interaction screening is important.

What to Expect When Starting an Antidepressant

  • Timeline: Antidepressants typically take 2–6 weeks to show meaningful effect on mood — some patients notice improvements in sleep and energy sooner.
  • Initial side effects: Nausea and activation often occur in the first week and usually resolve.
  • Give it time: Many providers recommend 4–8 weeks at a therapeutic dose before concluding a drug is not working.
  • Tapering: Never stop an antidepressant abruptly — discontinuation syndrome (dizziness, electric-shock sensations, flu-like symptoms) is common and can be severe with some drugs.
  • Not one-size-fits-all: Finding the right medication often takes trial and adjustment. This is normal.

Key Takeaways

  • SSRIs are the most commonly prescribed antidepressants — effective and generally well tolerated.
  • Receptor selectivity explains why different SSRIs have different side effect profiles.
  • SNRIs, bupropion, and mirtazapine offer alternatives with different advantages depending on your symptom profile.
  • Serotonin syndrome is a serious risk when combining serotonergic medications — always disclose all medications to each prescriber.
  • Antidepressants take weeks to work; dose tapering is needed before stopping.

संबंधित शब्दकोश शब्द

ये उपकरण आज़माएँ